Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Corcia

Showing results (71-80 of 235) with videos related to

Pageof 24
Sort By:
Environmental Research|June 22, 2019
Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based studyJaime Luna, Jean-Philippe Leleu, Pierre-Marie Preux, et al.
European Journal of Neurology|March 12, 2023
Evaluation of arterial blood gas parameters as prognostic markers in amyotrophic lateral sclerosisHugo Alarcan, Camille Cotet, Nadège Lépine, et al.
Biodata Mining|June 26, 2026
Learning a distance for the clustering of patients with amyotrophic lateral sclerosisGuillaume Tejedor Y Dominguez, Hugo Alarcan, Veronika Peralta, et al.
Expert Opinion on Therapeutic Targets|June 2, 2022
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic targetYara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, et al.
Medicine|January 27, 2015
Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case seriesMathilde Duchesne, Stéphane Mathis, Philippe Corcia, et al.
Case Reports in Neurological Medicine|January 4, 2017
Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic SyndromeStéphane Mathis, Laurent Magy, Philippe Corcia, et al.
Expert Opinion on Drug Discovery|January 22, 2026
The preclinical discovery and development of edaravone for the treatment of amyotrophic lateral sclerosis: what lessons have we learnt?Tifenn Charbonnel, Elodie Richard, Adrien Dupuis, et al.
Cells|October 2, 2020
Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient CellsRudolf Hergesheimer, Débora Lanznaster, Jérôme Bourgeais, et al.
European Journal of Neurology|May 20, 2023
Diagnostic delay in amyotrophic lateral sclerosisKelly G Gwathmey, Philippe Corcia, Chris J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2013
Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome?Anne-Marie Guennoc, Nathalie Heuze-Vourc'h, Paul H Gordon, et al.
Pageof 24

Showing results (71-80 of 235) with videos related to

Sort By:
Pageof 24
Environmental Research|June 22, 2019
Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based studyJaime Luna, Jean-Philippe Leleu, Pierre-Marie Preux, et al.
European Journal of Neurology|March 12, 2023
Evaluation of arterial blood gas parameters as prognostic markers in amyotrophic lateral sclerosisHugo Alarcan, Camille Cotet, Nadège Lépine, et al.
Biodata Mining|June 26, 2026
Learning a distance for the clustering of patients with amyotrophic lateral sclerosisGuillaume Tejedor Y Dominguez, Hugo Alarcan, Veronika Peralta, et al.
Expert Opinion on Therapeutic Targets|June 2, 2022
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic targetYara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, et al.
Medicine|January 27, 2015
Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case seriesMathilde Duchesne, Stéphane Mathis, Philippe Corcia, et al.
Case Reports in Neurological Medicine|January 4, 2017
Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic SyndromeStéphane Mathis, Laurent Magy, Philippe Corcia, et al.
Expert Opinion on Drug Discovery|January 22, 2026
The preclinical discovery and development of edaravone for the treatment of amyotrophic lateral sclerosis: what lessons have we learnt?Tifenn Charbonnel, Elodie Richard, Adrien Dupuis, et al.
Cells|October 2, 2020
Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient CellsRudolf Hergesheimer, Débora Lanznaster, Jérôme Bourgeais, et al.
European Journal of Neurology|May 20, 2023
Diagnostic delay in amyotrophic lateral sclerosisKelly G Gwathmey, Philippe Corcia, Chris J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2013
Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome?Anne-Marie Guennoc, Nathalie Heuze-Vourc'h, Paul H Gordon, et al.
Pageof 24